Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Comparing Two Electroconvulsive Therapy (ECT) Application Schemas in Ultra-resistant Schizophrenia

NCT03542903 is registered in ClinicalTrials.gov with Centre Hospitalier du Rouvray as lead sponsor.

NCT NCT03542903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03542903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Comparing Two Electroconvulsive Therapy (ECT) Application Schemas in Ultra-resistant Schizophrenia
Lead sponsor
Centre Hospitalier du Rouvray
Phase
Not applicable
Overall status
Unknown status
Start date
July 4, 2018
Completion date
October 4, 2023
Enrollment
64 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

electroconvulsive therapy, schizophrenia